Posted by Michael Wonder on 02 Dec 2025
Korea eases path to breakthrough drugs with flexible ICER rules
1 December 2025 - The Government has unveiled a large-scale overhaul of the health insurance drug pricing system, proposing flexible application of the incremental cost effectiveness ratio threshold and structural enhancement measures as its core components.
Previously, the absence of a fixed threshold, limitations on realistic acceptance ranges, and insufficient flexibility for new drugs targeting severe and rare diseases were cited as problems.
